0001387131-23-001468.txt : 20230206 0001387131-23-001468.hdr.sgml : 20230206 20230206161812 ACCESSION NUMBER: 0001387131-23-001468 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210812 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Medytox Inc. CENTRAL INDEX KEY: 0001848514 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1220 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38381 FILM NUMBER: 23590884 BUSINESS ADDRESS: STREET 1: 78, GANGNI 1-GIL, OCHANG-EUP, STREET 2: CHEONGWON-GU CITY: CHEOGJU-SI STATE: M5 ZIP: 28126 BUSINESS PHONE: 82-2-3471-8319 MAIL ADDRESS: STREET 1: 78, GANGNI 1-GIL, OCHANG-EUP, STREET 2: CHEONGWON-GU CITY: CHEOGJU-SI STATE: M5 ZIP: 28126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolus, Inc. CENTRAL INDEX KEY: 0001570562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461385614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: (949) 284-4555 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: SUITE 1200 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 4 1 ownership.xml CHANGES IN BENEFICIAL OWNERSHIP X0306 4 2021-08-12 0 0001570562 Evolus, Inc. EOLS 0001848514 Medytox Inc. 78, GANGNI 1-GIL, OCHANG-EUP, CHEONGWON-GU CHEOGIU-SI M5 28126 KOREA, REPUBLIC OF 0 0 1 0 Common Stock, $0.00001 par value per share 2021-08-12 4 P 0 23000 10.9902 A 7282500 I See Footnote Common Stock, $0.00001 par value per share 2021-08-13 4 P 0 14043 11.1133 A 7296543 I See Footnote Common Stock, $0.00001 par value per share 2023-01-20 4 S 0 37043 11.04 D 7259500 I See Footnote Inadvertently filed late due to an administrative error. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.88 to $11.10, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 to 2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.91 to $11.26, inclusive. The Issuer shares were previously held of record by Medytox Korea Co., Ltd. ("Medytox Korea"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership. /s/ Minjung Choi, Senior Manager, on behalf of Medytox Inc. 2023-02-06